Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

18.53 +0.15 (+0.82%)
Streaming Delayed Price Updated: 10:04 AM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
29 30 Next >
Teva Reports Fourth Quarter and Full Year 2022 Financial Results
From Teva Pharmaceutical Industries Limited
Via Business Wire
Nasdaq Bear Market: 3 Tantalizing Value Stocks That Can Double Your Money by 2026
These profitable companies are exceptionally cheap and ripe for the picking, following a 33% decline in the Nasdaq Composite. 
Via The Motley Fool
The 7 Best Growth Stocks to Buy for February 2023
Some of the best growth stocks are lesser-known names that have the ability to provide tremendous long-term upside for investors. 
Via InvestorPlace
Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review
Stocks reacted well to uneven earnings and economic reports. 
Via Investor's Business Daily
Analyst Ratings for Teva Pharmaceutical Indus
 
Via Benzinga
Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed?
Things aren't as bad as they might seem. 
Via The Motley Fool
6 Great Stocks to Buy in 2023 and Hold Forever
I own all six great businesses and don't plan to sell a single share. 
Via The Motley Fool
How Former IBD 50 Leader Catalyst Pharma Is Trying To Claw Back From A 29% Setback
Catalyst is adding to its portfolio with a $160 million deal. 
Via Investor's Business Daily
Nasdaq Bear Market: 3 Screaming Bargains That Can Double Your Money by 2025
A 33% plunge in the Nasdaq Composite is the opportune time to scoop up these exceptional deals. 
Via The Motley Fool
Dow, Nasdaq Boasting Triple-Digit Midday Lead
Investors seem intent on leaving last week's losses behind, as earnings season heats up. 
Via Talk Markets
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
 
Via Benzinga
3 Dirt Cheap Stocks to Buy in January
Bargains can easily be found as the new year gets underway. 
Via The Motley Fool
No. 1 IBD 50 Stock Catalyst Tanks As Teva Looks To Knock Off Its Only Product
Shares have sat atop the IBD 50 for weeks, have perfect ratings and recently hit a profit-taking zone. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023
 
Via Benzinga
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday
JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market... 
Via Benzinga
Teva’s Ambitious Climate Targets Externally Validated by the Science Based Targets initiative (SBTi)
From Teva Pharmaceutical Industries Limited
Via Business Wire
Organon Stock Scores Market Leadership With Jump To 83 RS Rating
Organon sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today
The stock has gone on a wild ride over the past few years. 
Via The Motley Fool
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023
From Teva Pharmaceutical Industries Limited
Via Business Wire
Most Active Equity Options For Midday - Wednesday, Jan. 11
Here are the most active equity options for midday. 
Via Talk Markets
NVAX Stock Alert: What to Know as Novavax Names New CEO
Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries. 
Via InvestorPlace
Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States
From Teva Pharmaceutical Industries Limited
Via Business Wire
4 Stocks That Actually Increased in 2022 -- And They're Still Worth Buying Now
These all handily outperformed the market last year and could do the same in 2023. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
From Teva Pharmaceutical Industries Limited
Via Business Wire
Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
From Alvotech
Via GlobeNewswire
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
Jazz Pharmaceuticals (NASDAQ: JAZZ), a drug company behind the CBD-based medication Epidiolex, recently filed a lawsuit against Teva Pharmaceutical Industries Ltd (NYS 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
2023 Kick-Off With Apple Losing $2T With Big Option Trades On GLD And XLE
While the tenor was more bearish, the late-day rally found the market close to where it finished 2022. 
Via Talk Markets
Teva to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Teva Pharmaceutical Industries Limited
Via Business Wire
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.